Nanjing Medlander Medical Technology Co (SHSE:688273) Ending Cash Position : ¥454.9 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Nanjing Medlander Medical Technology Co Ending Cash Position?

Nanjing Medlander Medical Technology Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥454.9 Mil.

Nanjing Medlander Medical Technology Co's quarterly Ending Cash Position declined from Sep. 2024 (¥573.8 Mil) to Dec. 2024 (¥441.6 Mil) but then increased from Dec. 2024 (¥441.6 Mil) to Mar. 2025 (¥454.9 Mil).

Nanjing Medlander Medical Technology Co's annual Ending Cash Position declined from Dec. 2022 (¥1,175.8 Mil) to Dec. 2023 (¥991.6 Mil) and declined from Dec. 2023 (¥991.6 Mil) to Dec. 2024 (¥441.6 Mil).

Nanjing Medlander Medical Technology Co Ending Cash Position Historical Data

The historical data trend for Nanjing Medlander Medical Technology Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Medlander Medical Technology Co Ending Cash Position Chart

Nanjing Medlander Medical Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

149.82

272.12

1,175.83

991.63

441.56

Nanjing Medlander Medical Technology Co Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															986.74	907.62	573.80	441.56	454.89

Nanjing Medlander Medical Technology Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Nanjing Medlander Medical Technology Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	991.628	+	-550.069
	=	441.6

Nanjing Medlander Medical Technology Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	441.559	+	13.329
	=	454.9

Nanjing Medlander Medical Technology Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Nanjing Medlander Medical Technology Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Medlander Medical Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Medlander Medical Technology Co Ltd (SHSE:688273) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2, Gande Road, 2nd Floor, Building 5, Jiangning High-tech Park, Jiangning District, Jiangsu Province, Nanjing City, CHN, 211100

Website

http://www.medlander.com

Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales and service of related products in the field of pelvic floor and postpartum rehabilitation.

Executives

Zhu Bi Sheng	senior management
Chen Jiang Ning	senior management
Yang Rui Jia	Directors, senior managers, core technical personn
Shi Zhi Huai	Directors, senior managers, core technical personn
Chen Bin	Directors, senior managers
Tu Hong Lin	Directors, senior managers
Wang Wang	senior management

Nanjing Medlander Medical Technology Co Headlines

No Headlines